(CTHA) as prognostic and predictive factor in platinum-refractory non-small cell lung
carcinoma (NSCLC) treated with immune checkpoint inhibitor Nivolumab. Method One
hundred and four patients were enrolled from 3 different centers. CT was performed using
similar parameters among different scanners. CTHA was performed with the proprietary
software TexRAD, which extracts histogram features at different spatial scale (spatial scale …